TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.
Also called NCT03145194
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 140 participants
- Registry
-
NCT03145194
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT03145194. Randomized; triple masking; primary purpose treatment. Start 2017-01-30 (actual); primary completion 2018-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Drug)
- Ticagrelor
- Intervention (Other)
- Placebo
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct03145194- Content hash
a0bbea5717a0584bbe2fe3664600d90123713a4833ef1c630cac70885388e891